A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants

NCT07442591 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healhty

Interventions

DRUG: Carbidopa and Levodopa Controlled-Release Tablets (25 mg/150 mg)
DRUG: Carbidopa and Levodopa Controlled-Release Tablets (25 mg/150 mg)
DRUG: Carbidopa and Levodopa Controlled-Release Tablets (25 mg/150 mg)

Sponsor

Shanghai WD Pharmaceutical Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]